Agios Pharmaceuticals
AGIO
AGIO
236 hedge funds and large institutions have $1.67B invested in Agios Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 79 increasing their positions, 69 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.91% less ownership
Funds ownership: 109.28% → 105.37% (-3.9%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
35% less capital invested
Capital invested by funds: $2.55B → $1.67B (-$878M)
Holders
236
Holding in Top 10
3
Calls
$133M
Puts
$45.6M
Top Buyers
| 1 | +$79.7M | |
| 2 | +$51.6M | |
| 3 | +$45.7M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$30.1M |
Top Sellers
| 1 | -$149M | |
| 2 | -$107M | |
| 3 | -$93.9M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$78.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$65.7M |
